The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 18, 2014

Filed:

Jul. 01, 2011
Applicants:

Nigel Graham Cooke, Oberwil, CH;

Paulo Fernandes Gomes Dos Santos, Basel, CH;

Nadege Graveleau, Hesingue, FR;

Christina Hebach, Muenchenstein, CH;

Klemens Högenauer, Oberwil, CH;

Gregory Hollingworth, Sevenoaks, GB;

Alexander Baxter Smith, Niffer, FR;

Nicolas Soldermann, Rosenau, FR;

Frank Stowasser, Murg, DE;

Ross Strang, Haut-Rhin, FR;

Nicola Tufilli, Moehlin, CH;

Anette Von Matt, Biel-Benken, CH;

Romain Wolf, Schlierbach, FR;

Frédéric Zecri, Brookline, MA (US);

Inventors:

Nigel Graham Cooke, Oberwil, CH;

Paulo Fernandes Gomes Dos Santos, Basel, CH;

Nadege Graveleau, Hesingue, FR;

Christina Hebach, Muenchenstein, CH;

Klemens Högenauer, Oberwil, CH;

Gregory Hollingworth, Sevenoaks, GB;

Alexander Baxter Smith, Niffer, FR;

Nicolas Soldermann, Rosenau, FR;

Frank Stowasser, Murg, DE;

Ross Strang, Haut-Rhin, FR;

Nicola Tufilli, Moehlin, CH;

Anette Von Matt, Biel-Benken, CH;

Romain Wolf, Schlierbach, FR;

Frédéric Zecri, Brookline, MA (US);

Assignee:

Novartis AG, Basel, CH;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 471/04 (2006.01); A61K 31/519 (2006.01); A61P 37/08 (2006.01); A61P 25/28 (2006.01); A61P 35/00 (2006.01); A61P 37/06 (2006.01);
U.S. Cl.
CPC ...
Abstract

The invention relates to substituted tetrahydro-pyrido-pyrimidine derivatives of the formula (I), wherein Y, R, Rand m are as defined in the description. Such compounds are suitable for the treatment of a disorder or disease which is mediated by the activity of the PI3K enzymes.


Find Patent Forward Citations

Loading…